Facilities

Diatec’s HQ and GMP facility is located in Oslo Science Park.  The current facility was designed by ourselves (2012), in collaboration with technical experts to give us an effective and flexible production unit and analytical laboratory. The GMP production facilities were later upgraded in 2019 when it was decided to separate the ISO and GMP sites. 

From January 2019, the ISO production facility has been stituated at Technopolis Fornebu.

The split of the two sites is a part of our strategy of risk reduction and increase in production capacity

Contact us

History

2021
The ISO production facilitiy at Technopolis is upgraded to increase efficiency and capacity

2020
Funding from The Norwegian Research Council to work on automatization / robotization of antibody production

2019
The GMP facility at Oslo Science Park is upgraded and the ISO production facilitiy is moved to Technopolis Fornebu.

2018
Funding from The Norwegian Research Council to develop new production technologies for biopharmaceuticals

2014
Manufacturing Certificate of GMP Compliance for production of API is achieved

2013
Second commission for the same A.P.I. for Phase I and II trials

2012
Diatec moves into new facilities with state of the art laboratories and clean rooms in Oslo Science Park

2011
First commission to produce an Active Pharmaceutical Ingredient (A.P.I.) for a new cancer drug

2005
Diatec Monoclonals focuses on soley being a monoclonal antibody service business

1998
Diatec achieves ISO 9001 certification, later upgraded to 9001:2015

1996
Diatec moves into Oslo Science Park

1990’s
Development of own diagnostic kits and increased range of monoclonal antibodies

1988
Diatec is founded as a distribution company for clinical diagnostic products